Moderna’s stock is falling. Goldman Sachs says it’s no longer a buy.
Shares of vaccine maker Moderna fell Wednesday as Goldman Sachs lowered its rating after the biotech’s second cut to product ...
Yahoo Finance22d
Goldman Dropped Complex Debt Swap After Internal Risk Review
(Bloomberg) -- Goldman Sachs Group Inc. pulled out of a $1 billion ... was completed last month — after an internal compliance review identified a possible conflict of interest that the bank ...